Skip to main content

Greenfield Seitz Capital Management, LLC

Position in NVO — Novo Nordisk A S

CIK 2097528 DALLAS, TX

Position in NVO

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$5,886,648
+$1,462,720 QoQ
Shares Held
122,792
+2.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.79%
of 13F equity value
Holder Rank
#193
of 1,348 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Greenfield Seitz Capital Management, LLC holds $12,882,900 across 5 Drug Manufacturers - General names. NVO ranks #1 (45.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NVO
Novo Nordisk A S
This page
122,792 $5,886,648

All Filings in NVO

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,886,648 122,792
2026-03-31 $4,423,928 120,379
2025-12-31 $5,107,232 100,378
2025-09-30 $5,380,310 96,960
2025-06-30 $5,798,508 84,012
2025-03-31 $5,461,456 78,650
2024-12-31 $6,498,811 75,550
2024-09-30 $7,770,746 65,262
2024-06-30 $9,551,018 66,912
2024-03-31 $8,966,814 69,835
2023-12-31 $7,502,504 72,523